Picard Medical raises $5M in public offering, receives NYSE American delisting notice for low equity

Picard Medical, Inc.

• Gross proceeds of $5.0M from sale of ~16.7M shares (or pre-funded warrants) and Series A/B warrants at $0.30 per unit.
• Proceeds used for working capital and debt repayment; offering closed May 6, 2026.
• NYSE American notified stockholders' equity of $3.8M as of Dec 31, 2025 is below $4M threshold; PMI must submit compliance plan by June 7, 2026.
• Regain compliance deadline Nov 8, 2027; stock continues trading with '.BC' indicator.
• Company directors and officers subject to 30-day lock-up; 60-day company restriction on further issuance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.